Melguizo Alonso, Consolación Author
Drug resistance induced by paclitaxel and carboplatin plasmatic concentrations in lung cancer cell lines
- Luque, Raquel
- Gonazlez Vicente, Aranzazu
- Soberino, Jesus
- Carlos Prados, Jose
- Melguizo, Consolacion
- Gonzalez Rivas, Cynthia S.
- Ruiz Vozmediano, Julia
- Conde, Veronica
- Garcia Garcia, Javier
- Aranega, Antonia
JOURNAL OF CLINICAL ONCOLOGY - 20/10/2012
10.1200/jco.2012.30.30_suppl.97
- SJR Quartile: Q1
- JCR Impact Factor: 18.038 (2012)
- JCR 5-year Impact Factor: 17.255
- JCR Categories: ONCOLOGY
- SJR Categories: Cancer Research (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1)
Drug resistance induced by plasmatic concentrations of paclitaxel and carboplatin
- Luque, R.
- Gonzalez Flores, E.
- Delgado, J. R.
- Prados, J. C.
- Melguizo, C.
- Conde, V.
- Gonzalez Astorga, B.
- Ortiz, R.
- Rama, A.
JOURNAL OF CLINICAL ONCOLOGY - 20/05/2011
10.1200/jco.2011.29.15_suppl.e13036
- SJR Quartile: Q1
- JCR Impact Factor: 18.372 (2011)
- JCR 5-year Impact Factor: 16.762
- JCR Categories: ONCOLOGY
- SJR Categories: Cancer Research (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1)
Mdr1 gene expression as a marker of treatment response in non-small cell lung cancer (NSCLC)
- Luque, R.
- Melguizo, C.
- Gonzalez, E.
- Prados, J. C.
- Martinez, J.
- Rama, A.
- Valdivia, J.
- Ortiz, R.
- Conde, V.
- Delgado, J. R.
JOURNAL OF CLINICAL ONCOLOGY - 20/05/2010
10.1200/jco.2010.28.15_suppl.e13151
- SJR Quartile: Q1
- JCR Impact Factor: 18.97 (2010)
- JCR 5-year Impact Factor: 16.429
- JCR Categories: ONCOLOGY
- SJR Categories: Cancer Research (Q1); Medicine (miscellaneous) (Q1); Oncology (Q1)
Circulating PTGS2, JAG1, GUCY2C and PGF mRNA in Peripheral Blood and Serum as Potential Biomarkers for Patients with Metastatic Colon Cancer
- Cristina Jimenez-Luna
- Encarnación González-Flores
- Raul Ortiz
- Luis Javier Martinez-Gonzalez
- Antúnez-Rodríguez, A.
- Manuela Expósito-Ruiz
- Consolación Melguizo Alonso
- Caba, O
- Jose Prados
Journal of Clinical Medicine - 22/05/2021
- JCR Impact Factor: 4.964 (2021)
- JCR 5-year Impact Factor: 5.098
- JCR Categories: MEDICINE, GENERAL & INTERNAL
- Scopus
- ORCID
- Web of Science
Current status of immunotherapy treatments for pancreatic cancer
- Jimenez-Luna, Cristina
- Prados, Jose
- Ortiz, Raul
- Melguizo, Consolacion
- Torres, Carolina
- Caba, Octavio
Journal of Clinical Gastroenterology - 1/11/2016
- SJR Quartile: Q1
- JCR Impact Factor: 3.328 (2016)
- CiteScore: 5.2 (2020)
- SJR: 1.408 (2016
- SNIP: 1.294 (2016
- JCR 5-year Impact Factor: 3.246
- JCR Categories: GASTROENTEROLOGY & HEPATOLOGY
- SJR Categories: Gastroenterology (Q1)
- Scopus
- ORCID
- Web of Science
Changes in subcellular accumulation of contractile proteins in myocardiocyte cultures: Effects of fibric acid derivatives
- VELEZ, C
- ARANEGA, AE
- MUROS, MA
- MELGUIZO, C
- GONZALEZ, AR
- ALVAREZ, L
- ARANEGA, A
Journal of Cardiovascular Pharmacology - 1/01/1993
10.1097/00005344-199301000-00007
- CiteScore: 3.7 (2020)
- Scopus
- ORCID
- Web of Science
Modulation of contractile protein troponin-T in chick myocardial cells by basic fibroblast growth factor and platelet-derived growth factor during development
- VELEZ, C
- ARANEGA, AE
- MELGUIZO, C
- FERNANDEZ, JE
- PRADOS, J
- ARANEGA, A
Journal of Cardiovascular Pharmacology - 1/12/1994
10.1097/00005344-199424060-00007
- CiteScore: 3.7 (2020)
- Scopus
- ORCID
- Web of Science
Identification of PARP-1 in cancer stem cells of gastrointestinal cancers: A preliminary study
- Quiñonero F.
- Cepero A.
- Urbano D.
- Muñoz-Gámez J.A.
- Martín-Guerrero S.M.
- Martín-Oliva D.
- Prados J.
- Melguizo C.
- Ortiz R.
Journal of Biosciences - 1/12/2021
- JCR Impact Factor: 2.795 (2021)
- CiteScore: 2.1 (2020)
- SJR: 0.459 (2020
- SNIP: 0.489 (2020
- JCR 5-year Impact Factor: 2.712
- JCR Categories: BIOLOGY
- Scopus
- ORCID
- Web of Science
MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression
- Oliver J.A.
- Ortiz R.
- Jiménez-Luna C.
- Cabeza L.
- Perazzoli G.
- Caba O.
- Mesas C.
- Melguizo C.
- Prados J.
Journal of Biosciences - 1/12/2020
- JCR Quartile: Q3 (2020)
- JCR Impact Factor: 1.826 (2022)
- Category normalized Impact: 0.383 (2020)
- CiteScore: 2.1 (2020)
- SJR: 0.459 (2020
- SNIP: 0.489 (2020
- JCR 5-year Impact Factor: 2.107
- JCR Categories: BIOLOGY
- Scopus
- ORCID
- Web of Science
Construction of a new recombinant adenovirus: possible uses in gene therapy
- Peran, M.
- Velez, C.
- Boulaiz, H.
- Marchal, J. A.
- Rodriguez-Serrano, F.
- Melguizo, C.
- Prados, J. C.
- Martinez-Amat, A.
- Hita, F.
- Caba, O.
- Aranega, A.
JOURNAL OF ANATOMY - 05/2007
- SJR Quartile: Q1
- SJR Categories: Anatomy (Q1); Ecology, Evolution, Behavior and Systematics (Q1); Histology (Q1); Cell Biology (Q2); Developmental Biology (Q2); Molecular Biology (Q2)
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
This author has no conferences.
This author has no patents.
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador